Hexo is the latest Canadian cannabis producer to run afoul of the New York Stock Exchange’s continued listing standards due to a low stock price.
The Ontario-based company was warned by the NYSE last month that its shares, which have fallen below $1, do not meet the exchange’s listing standards.
Hexo said it receiving the notification April 7 before notifying shareholders via a press release May 13.
As a result, Hexo now has until Dec. 16, 2020 to regain compliance.
Compliance can be regained if Hexo’s shares achieve a 30 trading day average closing price of at least $1 per share.
If Hexo’s shares do not regain the $1 threshold by then, the NYSE will commence suspension and delisting procedures.
The company is considering its options to regain compliance, including a share consolidation, “if necessary.”
Hexo joins Alberta-based Aurora Cannabis and beleaguered producer CannTrust on the list of cannabis companies running into trouble with the NYSE.
Aurora recently consolidated its shares to boost its sagging stock price and maintain its NYSE listing.
Beleaguered Canadian cannabis producer CannTrust was delisted from the NYSE on April 27.
Hexo booked a net loss of 298 million Canadian dollars ($220 million) in its most recent quarter ending Jan. 31.
Pure CBD Hemp Oil
- Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.
- Clinically proven therapeutic effects.
- Relieves anxiety and stress
- Eliminates chronic pain and aches
- Regulates mood and sleep patterns
- Enhances focus and clarity
george scorsis
Originally posted on via Cannabis Industry News
No comments:
Post a Comment